[1]
“Immunophenotypic Expression and its Association with Prognostic Factors, Clinical Stages, and Clinical Profiles in Newly Diagnosed Patients with Plasma Cell Myeloma: Insights from Two Tertiary Care Centers”, Biomed. Res. Ther., vol. 11, no. 3, pp. 6248–6261, Mar. 2024, doi: 10.15419/bmrat.v11i3.870.